ITMI20021455A0 - Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeutico - Google Patents
Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeuticoInfo
- Publication number
- ITMI20021455A0 ITMI20021455A0 IT2002MI001455A ITMI20021455A ITMI20021455A0 IT MI20021455 A0 ITMI20021455 A0 IT MI20021455A0 IT 2002MI001455 A IT2002MI001455 A IT 2002MI001455A IT MI20021455 A ITMI20021455 A IT MI20021455A IT MI20021455 A0 ITMI20021455 A0 IT MI20021455A0
- Authority
- IT
- Italy
- Prior art keywords
- lexitropsine
- phospholipide
- formulations
- preparation
- therapeutic use
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2002MI001455A ITMI20021455A1 (it) | 2002-07-02 | 2002-07-02 | Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeutico |
US10/519,889 US20060067997A1 (en) | 2002-07-02 | 2003-06-26 | Phospholipid complexes of lexitropsins, their preparation and use in therapeutic formulations |
JP2004518585A JP2006505506A (ja) | 2002-07-02 | 2003-06-26 | レキシトロプシンのリン脂質複合体、その製造及び治療剤への使用 |
EP03762519A EP1536771A1 (en) | 2002-07-02 | 2003-06-26 | Phospholipid complexes of lexitropsins, their preparation and use in therapeutic formulations |
CA002491257A CA2491257A1 (en) | 2002-07-02 | 2003-06-26 | Phospholipid complexes of lexitropsins, their preparation and use in therapeutic formulations |
PCT/EP2003/006745 WO2004004691A1 (en) | 2002-07-02 | 2003-06-26 | Phospholipid complexes of lexitropsins, their preparation and use in therapeutic formulations |
AU2003250849A AU2003250849A1 (en) | 2002-07-02 | 2003-06-26 | Phospholipid complexes of lexitropsins, their preparation and use in therapeutic formulations |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2002MI001455A ITMI20021455A1 (it) | 2002-07-02 | 2002-07-02 | Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeutico |
Publications (2)
Publication Number | Publication Date |
---|---|
ITMI20021455A0 true ITMI20021455A0 (it) | 2002-07-02 |
ITMI20021455A1 ITMI20021455A1 (it) | 2004-01-02 |
Family
ID=11450127
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT2002MI001455A ITMI20021455A1 (it) | 2002-07-02 | 2002-07-02 | Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeutico |
Country Status (7)
Country | Link |
---|---|
US (1) | US20060067997A1 (it) |
EP (1) | EP1536771A1 (it) |
JP (1) | JP2006505506A (it) |
AU (1) | AU2003250849A1 (it) |
CA (1) | CA2491257A1 (it) |
IT (1) | ITMI20021455A1 (it) |
WO (1) | WO2004004691A1 (it) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20031015A1 (it) * | 2003-05-20 | 2004-11-21 | Naxospharma S R L | Poli-(amminopirrolcarbossammidi) per uso nella profilassi e nel trattamento delle endoparassitosi animali e loro composizioni con ciclodestrine. |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8517922D0 (en) * | 1985-07-16 | 1985-08-21 | Erba Farmitalia | Carboxamido derivatives |
US6187572B1 (en) * | 1990-04-16 | 2001-02-13 | Baxter International Inc. | Method of inactivation of viral and bacterial blood contaminants |
NZ514133A (en) * | 1996-10-15 | 2001-09-28 | Liposome Co Inc | N-acyl phosphatidylethanolamine-mediated liposomal drug delivery |
ES2327313T3 (es) * | 1999-11-16 | 2009-10-28 | Oncozyme Pharma Inc. | Pentamidina para el tratamiento del cancer. |
EP1294713A2 (en) * | 2000-06-27 | 2003-03-26 | Genelabs Technologies, Inc. | Compounds possessing antibacterial, antifungal or antitumor activity |
-
2002
- 2002-07-02 IT IT2002MI001455A patent/ITMI20021455A1/it unknown
-
2003
- 2003-06-26 CA CA002491257A patent/CA2491257A1/en not_active Abandoned
- 2003-06-26 WO PCT/EP2003/006745 patent/WO2004004691A1/en not_active Application Discontinuation
- 2003-06-26 AU AU2003250849A patent/AU2003250849A1/en not_active Abandoned
- 2003-06-26 US US10/519,889 patent/US20060067997A1/en not_active Abandoned
- 2003-06-26 JP JP2004518585A patent/JP2006505506A/ja active Pending
- 2003-06-26 EP EP03762519A patent/EP1536771A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP2006505506A (ja) | 2006-02-16 |
AU2003250849A1 (en) | 2004-01-23 |
CA2491257A1 (en) | 2004-01-15 |
WO2004004691A1 (en) | 2004-01-15 |
ITMI20021455A1 (it) | 2004-01-02 |
US20060067997A1 (en) | 2006-03-30 |
EP1536771A1 (en) | 2005-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS7714A (is) | Lyfjasamsetningar úr módafíníl | |
NO20044402L (no) | Kombinasjonsbehandling av kemokine-medierte sykdommer | |
CY2013043I1 (el) | Ενωσεις 4-οξοκινολινης και χρησιμοποιηση αυτων ως αναστολεις της ενσωματασης του hiv | |
CY2018005I1 (el) | Απο του στοματος φαρμακοτεχνικες μορφες της κλαντριβινης | |
IS2707B (is) | Nýjar lyfjasamsetningar úr módafíníli | |
HK1164133A1 (en) | Nasal pharmaceutical formulations and methods of using the same | |
NO20044054L (no) | Administrering av midler for behandling av betennelse | |
FIU20060389U0 (fi) | Luusairauksien hoito | |
AU2003287526A8 (en) | Protein-stabilized liposomal formulations of pharmaceutical agents | |
NO20042842L (no) | Farmasoytiske formuleringer av platina-derivat | |
HK1091727A1 (en) | Nasal pharmaceutical formulations and methods of using the same | |
CY2018006I1 (el) | Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας | |
NO20044916L (no) | Preparater av sulfinylacetamid | |
IS6966A (is) | Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma | |
EP1560572A4 (en) | TOPICAL PEST FORMULATIONS AND METHODS OF TREATMENT | |
IS6967A (is) | Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma | |
IL162937A0 (en) | Pravastatin pharmaceutical formulations and methods of their use | |
EP1531795A4 (en) | FORMULATIONS LIMITING THE EXTENSION OF PULMONARY INFECTIONS | |
EE200300501A (et) | Ninna manustatavad imidasotriasinooni sisaldavad kompositsioonid | |
ZA200603542B (en) | Oral formulations of desoxypeganine and uses thereof | |
NO20041968L (no) | Anvendelse av cystationin | |
EE200300328A (et) | IL-18 inhibiitorite kasutamine südamehaiguse raviks ja/või ennetamiseks | |
DE60238174D1 (de) | Fluoropolymere und Herstellungs- und Verwendungsverfahren | |
ITMI20021455A0 (it) | Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeutico | |
EE200300434A (et) | Farmatseutiliselt toimivate ühendite kasutamine |